Endologix (ELGX) Posts Q1 Loss of $2.12/Share

Endologix (NASDAQ: ELGX) reported Q1 GAAP EPS of ($2.12), which does not compare to the the analyst estimate of ($1.55). Revenue for the quarter came in at $35.6 million versus the consensus estimate of $34.43 million.

For earnings history and earnings-related data on Endologix (ELGX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c